Michael S. Broder, MD
Articles
July 12th 2011
Cost-Effectiveness of 21-Gene Assay in Node-Positive, Early-Stage Breast Cancer
Burton F. Vanderlaan, MD Michael S. Broder, MD Eunice Y. Chang, PhD Ruth Oratz, MD, FACP Tanya G. K. Bentley, PhD
A decision-analytic model was used to estimate cost-effectiveness of adopting a 21-gene assay in treatment decisions for women with early-stage N (1-3)/ER HER2-negative breast cancer.
March 9th 2010
Ratio of Controller to Total Asthma Medications: Determinants of the Measure
Michael S. Broder, MD Benjamin Gutierrez, PhD Eunice Chang, PhD David Meddis, PhD Michael Schatz, MD
The ratio of controller to total asthma medications can be calculated using 1 or 2 quarters of data; high versus low ratios differentiate patient characteristics.
Latest Updated Articles
Published: November 15th 2024 | Updated: November 19th 2024
FDA Approves Revumenib for R/R Acute Leukemia With a KMT2A Translocation
Published: April 1st 2024 | Updated: November 5th 2024
What We're Reading: Concierge Nonprofit Hospitals; Kaiser Permanente Elderly Care Program; Health Care Not Among Top Voter Issues
Published: October 21st 2024 | Updated: October 24th 2024
Lower Diagnostic Error Rates Found Among Hospitalized Patients During Care Transitions
Published: September 26th 2024 | Updated: October 1st 2024
Addressing Natural Disaster Takes Cooperation, Preparation to Ensure Patient Health
Published: May 9th 2024 | Updated: May 21st 2024
FDA Accepts Nivolumab Subcutaneous Injection Application, With Potential to Boost Access to PD-1 Inhibitors
Published: January 2nd 2024 | Updated: December 3rd 2024
Patients With Eye Diseases at Increased Risk of Falls, Fractures
